Gil M Labrucherie Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gil M Labrucherie.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gil M Labrucherie. Gil M Labrucherie is General Counsel and Secretary in NEKTAR THERAPEUTICS ($NKTR) and SVP & Chief Financial Officer in NEKTAR THERAPEUTICS ($NKTR) and SVP & General Counsel in NEKTAR THERAPEUTICS ($NKTR) and SVP, COO & CFO in NEKTAR THERAPEUTICS ($NKTR).
Latest Insider Trading Transactions of Gil M Labrucherie
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 22.37 | 7,977 | 178,445 | 258,996 | 267 K to 259 K (-2.99 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 8.80 | 50,000 | 440,000 | 0 | |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 8.80 | 25,000 | 220,000 | 50,000 | |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 8.80 | 25,000 | 220,000 | 0 | |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 8.80 | 50,000 | 440,000 | 25,000 | |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.81 | 50,000 | 990,500 | 266,973 | 317 K to 267 K (-15.77 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 8.80 | 50,000 | 440,000 | 316,973 | 267 K to 317 K (+18.73 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.61 | 50,000 | 980,500 | 266,973 | 317 K to 267 K (-15.77 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 8.80 | 25,000 | 220,000 | 316,973 | 292 K to 317 K (+8.56 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 8.80 | 25,000 | 220,000 | 291,973 | 267 K to 292 K (+9.36 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 21.66 | 1,933 | 41,869 | 266,973 | 268.9 K to 267 K (-0.72 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 20.96 | 6,932 | 145,295 | 268,906 | 275.8 K to 268.9 K (-2.51 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.97 | 41,135 | 821,466 | 275,838 | 317 K to 275.8 K (-12.98 %) |
| Feb 04 2021 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 8.80 | 50,000 | 440,000 | 316,973 | 267 K to 317 K (+18.73 %) |
| Dec 22 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 18.75 | 71,500 | 1,340,625 | 71,500 | |
| Dec 22 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Grant | A | 0.00 | 40,000 | 0 | 266,973 | 227 K to 267 K (+17.62 %) |
| Sep 21 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.96 | 2,000 | 39,920 | 235,249 | 237.2 K to 235.2 K (-0.84 %) |
| Aug 19 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.68 | 2,000 | 39,360 | 237,249 | 239.2 K to 237.2 K (-0.84 %) |
| Aug 19 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.67 | 6,245 | 122,839 | 239,249 | 245.5 K to 239.2 K (-2.54 %) |
| May 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 22.62 | 2,000 | 45,240 | 245,494 | 247.5 K to 245.5 K (-0.81 %) |
| May 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 22.51 | 5,727 | 128,915 | 247,494 | 253.2 K to 247.5 K (-2.26 %) |
| Feb 20 2020 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 22.35 | 5,938 | 132,714 | 253,221 | 259.2 K to 253.2 K (-2.29 %) |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 21.79 | 29,000 | 631,910 | 29,000 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 21.79 | 71,550 | 1,559,075 | 71,550 | |
| Dec 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Grant | A | 0.00 | 40,150 | 0 | 259,159 | 219 K to 259.2 K (+18.33 %) |
| Nov 20 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 17.97 | 8,863 | 159,268 | 219,009 | 227.9 K to 219 K (-3.89 %) |
| Nov 15 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 7.21 | 25,000 | 180,250 | 0 | |
| Nov 15 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 19.79 | 25,000 | 494,750 | 227,872 | 252.9 K to 227.9 K (-9.89 %) |
| Nov 15 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 7.21 | 25,000 | 180,250 | 252,872 | 227.9 K to 252.9 K (+10.97 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | M | 7.21 | 25,000 | 180,250 | 25,000 | |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Sell | S | 15.83 | 25,000 | 395,750 | 227,872 | 252.9 K to 227.9 K (-9.89 %) |
| Oct 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Buy | M | 7.21 | 25,000 | 180,250 | 252,872 | 227.9 K to 252.9 K (+10.97 %) |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Option Exercise | A | 18.43 | 150,000 | 2,764,500 | 150,000 | |
| Oct 02 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP, COO & CFO | Grant | A | 0.00 | 75,000 | 0 | 227,872 | 152.9 K to 227.9 K (+49.06 %) |
| Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 50,000 | |
| Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 20.52 | 25,000 | 513,000 | 152,872 | 177.9 K to 152.9 K (-14.06 %) |
| Sep 18 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 177,872 | 152.9 K to 177.9 K (+16.35 %) |
| Aug 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 16.31 | 30,000 | 489,300 | 57,500 | |
| Aug 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 16.31 | 30,000 | 489,300 | 152,872 | 122.9 K to 152.9 K (+24.42 %) |
| Aug 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 18.15 | 5,063 | 91,893 | 122,872 | 127.9 K to 122.9 K (-3.96 %) |
| Aug 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 0 | |
| Aug 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 17.79 | 25,000 | 444,750 | 127,935 | 152.9 K to 127.9 K (-16.35 %) |
| Aug 16 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 152,935 | 127.9 K to 152.9 K (+19.54 %) |
| Jul 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 25,000 | |
| Jul 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 34.57 | 25,000 | 864,250 | 127,935 | 152.9 K to 127.9 K (-16.35 %) |
| Jul 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 152,935 | 127.9 K to 152.9 K (+19.54 %) |
| Jun 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 7.21 | 25,000 | 180,250 | 50,000 | |
| Jun 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 33.71 | 25,000 | 842,750 | 127,935 | 152.9 K to 127.9 K (-16.35 %) |
| Jun 19 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 7.21 | 25,000 | 180,250 | 152,935 | 127.9 K to 152.9 K (+19.54 %) |
| May 17 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 31.37 | 3,767 | 118,171 | 127,935 | 131.7 K to 127.9 K (-2.86 %) |
| Feb 21 2019 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 42.39 | 3,592 | 152,265 | 131,702 | 135.3 K to 131.7 K (-2.65 %) |
| Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 36.51 | 58,100 | 2,121,231 | 58,100 | |
| Dec 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 28,750 | 0 | 135,294 | 106.5 K to 135.3 K (+26.98 %) |
| Nov 19 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 38.25 | 6,515 | 249,199 | 106,544 | 113.1 K to 106.5 K (-5.76 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 56.90 | 65,000 | 3,698,500 | 65,000 | |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 56.90 | 65,000 | 3,698,500 | 65,000 | |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | D | 58.40 | 8,207 | 479,289 | 113,059 | 121.3 K to 113.1 K (-6.77 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | D | 58.40 | 8,207 | 479,289 | 113,059 | 121.3 K to 113.1 K (-6.77 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 26,000 | 0 | 121,266 | 95.3 K to 121.3 K (+27.29 %) |
| Aug 16 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 26,000 | 0 | 121,266 | 95.3 K to 121.3 K (+27.29 %) |
| May 18 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 83.39 | 4,941 | 412,030 | 94,798 | 99.7 K to 94.8 K (-4.95 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 10.69 | 30,000 | 320,700 | 0 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 10.69 | 30,000 | 320,700 | 30,000 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 10.69 | 30,000 | 320,700 | 60,000 | |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 82.86 | 30,000 | 2,485,800 | 99,739 | 129.7 K to 99.7 K (-23.12 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 10.69 | 30,000 | 320,700 | 129,739 | 99.7 K to 129.7 K (+30.08 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 85.63 | 30,000 | 2,568,900 | 99,739 | 129.7 K to 99.7 K (-23.12 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 10.69 | 30,000 | 320,700 | 129,739 | 99.7 K to 129.7 K (+30.08 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 83.65 | 30,000 | 2,509,500 | 99,739 | 129.7 K to 99.7 K (-23.12 %) |
| May 03 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 10.69 | 30,000 | 320,700 | 129,739 | 99.7 K to 129.7 K (+30.08 %) |
| Feb 20 2018 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 82.94 | 3,477 | 288,382 | 99,739 | 103.2 K to 99.7 K (-3.37 %) |
| Dec 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 56.90 | 65,000 | 3,698,500 | 65,000 | |
| Dec 19 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 26,000 | 0 | 103,216 | 77.2 K to 103.2 K (+33.67 %) |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 14.41 | 50,000 | 720,500 | 50,000 | |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | D | 44.23 | 6,698 | 296,253 | 76,716 | 83.4 K to 76.7 K (-8.03 %) |
| Nov 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 20,000 | 0 | 83,414 | 63.4 K to 83.4 K (+31.54 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 11.34 | 120,000 | 1,360,800 | 0 | |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 24.45 | 120,000 | 2,934,000 | 63,414 | 183.4 K to 63.4 K (-65.43 %) |
| Oct 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 11.34 | 120,000 | 1,360,800 | 183,414 | 63.4 K to 183.4 K (+189.23 %) |
| Aug 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 19.32 | 3,177 | 61,380 | 63,414 | 66.6 K to 63.4 K (-4.77 %) |
| May 18 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 19.55 | 3,179 | 62,149 | 66,091 | 69.3 K to 66.1 K (-4.59 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 9.24 | 25,000 | 231,000 | 0 | |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 6.34 | 7,494 | 47,512 | 0 | |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | M | 6.34 | 167,506 | 1,061,988 | 7,494 | |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.21 | 25,000 | 380,250 | 69,270 | 94.3 K to 69.3 K (-26.52 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 9.24 | 25,000 | 231,000 | 94,270 | 69.3 K to 94.3 K (+36.09 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.21 | 7,494 | 113,984 | 69,270 | 76.8 K to 69.3 K (-9.76 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 6.34 | 7,494 | 47,512 | 76,764 | 69.3 K to 76.8 K (+10.82 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 15.15 | 167,506 | 2,537,716 | 69,270 | 236.8 K to 69.3 K (-70.74 %) |
| Mar 03 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Buy | M | 6.34 | 167,506 | 1,061,988 | 236,776 | 69.3 K to 236.8 K (+241.82 %) |
| Feb 17 2017 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 13.14 | 2,359 | 30,997 | 69,270 | 71.6 K to 69.3 K (-3.29 %) |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 12.24 | 50,000 | 612,000 | 50,000 | |
| Dec 15 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 20,000 | 0 | 71,629 | 51.6 K to 71.6 K (+38.74 %) |
| Nov 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 13.96 | 1,654 | 23,090 | 51,129 | 52.8 K to 51.1 K (-3.13 %) |
| Aug 17 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Sell | S | 17.56 | 3,305 | 58,036 | 52,783 | 56.1 K to 52.8 K (-5.89 %) |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 16.31 | 87,500 | 1,427,125 | 87,500 | |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 15.55 | 22,000 | 342,100 | 22,000 | |
| Jul 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Grant | A | 0.00 | 26,000 | 0 | 34,421 | 8.4 K to 34.4 K (+308.75 %) |
| Jun 03 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & Chief Financi ... | Option Exercise | A | 15.53 | 100,000 | 1,553,000 | 100,000 | |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | D | 0.00 | 2,167 | 0 | 21,667 | |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 13.58 | 836 | 11,353 | 7,921 | 8.8 K to 7.9 K (-9.55 %) |
| May 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 0.00 | 2,167 | 0 | 8,757 | 6.6 K to 8.8 K (+32.88 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | D | 0.00 | 2,166 | 0 | 23,834 | |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 11.92 | 827 | 9,858 | 6,590 | 7.4 K to 6.6 K (-11.15 %) |
| Feb 18 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 0.00 | 2,166 | 0 | 7,417 | 5.3 K to 7.4 K (+41.25 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,666 | 75,362 | 0 | |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 11.49 | 11,666 | 134,042 | 5,251 | 16.9 K to 5.3 K (-68.96 %) |
| Feb 12 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,666 | 75,362 | 16,917 | 5.3 K to 16.9 K (+222.17 %) |
| Jan 21 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,667 | 75,369 | 11,666 | |
| Jan 21 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 14.12 | 11,667 | 164,738 | 5,251 | 16.9 K to 5.3 K (-68.96 %) |
| Jan 21 2016 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,667 | 75,369 | 16,918 | 5.3 K to 16.9 K (+222.19 %) |
| Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 15.55 | 26,000 | 404,300 | 26,000 | |
| Dec 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | A | 0.00 | 22,000 | 0 | 22,000 | |
| Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,667 | 75,369 | 23,333 | |
| Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,334 | 232,671 | 0 | |
| Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 15.87 | 45,001 | 714,166 | 5,251 | 50.3 K to 5.3 K (-89.55 %) |
| Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,667 | 75,369 | 50,252 | 38.6 K to 50.3 K (+30.24 %) |
| Dec 07 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,334 | 232,671 | 38,585 | 5.3 K to 38.6 K (+634.81 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,667 | 75,369 | 35,000 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 33,334 | |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 13.52 | 45,000 | 608,400 | 4,751 | 49.8 K to 4.8 K (-90.45 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,667 | 75,369 | 49,751 | 38.1 K to 49.8 K (+30.63 %) |
| Nov 13 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,667 | 75,369 | 46,667 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 66,667 | |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 10.99 | 45,000 | 494,550 | 4,751 | 49.8 K to 4.8 K (-90.45 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,667 | 75,369 | 49,751 | 38.1 K to 49.8 K (+30.63 %) |
| Oct 08 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.46 | 11,666 | 75,362 | 58,334 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 100,000 | |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 13.04 | 44,999 | 586,787 | 4,751 | 49.8 K to 4.8 K (-90.45 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.46 | 11,666 | 75,362 | 49,750 | 38.1 K to 49.8 K (+30.63 %) |
| Sep 25 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,333 | 232,664 | 133,333 | |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 10.89 | 33,333 | 362,996 | 4,751 | 38.1 K to 4.8 K (-87.52 %) |
| Aug 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,333 | 232,664 | 38,084 | 4.8 K to 38.1 K (+701.60 %) |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Option Exercise | M | 6.98 | 33,334 | 232,671 | 166,666 | |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Sell | S | 11.78 | 33,334 | 392,675 | 4,251 | 37.6 K to 4.3 K (-88.69 %) |
| Jul 16 2015 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | SVP & General Couns ... | Buy | M | 6.98 | 33,334 | 232,671 | 37,585 | 4.3 K to 37.6 K (+784.14 %) |
| Apr 04 2007 | NKTR | NEKTAR THERAPEUTIC ... | Labrucherie Gil M | General Counsel and ... | Option Exercise | A | 13.02 | 10,500 | 136,710 | 50,400 |
Page: 1